ETXPF
Price
$0.13
Change
-$0.01 (-7.14%)
Updated
Apr 16 closing price
Capitalization
75.96M
KTTA
Price
$0.89
Change
+$0.01 (+1.14%)
Updated
Jun 6 closing price
Capitalization
6.59M
Interact to see
Advertisement

ETXPF vs KTTA

Header iconETXPF vs KTTA Comparison
Open Charts ETXPF vs KTTABanner chart's image
E-Therapeutics
Price$0.13
Change-$0.01 (-7.14%)
Volume$10K
Capitalization75.96M
Pasithea Therapeutics
Price$0.89
Change+$0.01 (+1.14%)
Volume$160.37K
Capitalization6.59M
ETXPF vs KTTA Comparison Chart
Loading...
KTTA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ETXPF vs. KTTA commentary
Jun 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ETXPF is a Buy and KTTA is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 07, 2025
Stock price -- (ETXPF: $0.13 vs. KTTA: $0.89)
Brand notoriety: ETXPF and KTTA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ETXPF: 100% vs. KTTA: 2%
Market capitalization -- ETXPF: $75.96M vs. KTTA: $6.59M
ETXPF [@Biotechnology] is valued at $75.96M. KTTA’s [@Biotechnology] market capitalization is $6.59M. The market cap for tickers in the [@Biotechnology] industry ranges from $324.3B to $0. The average market capitalization across the [@Biotechnology] industry is $2.35B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ETXPF’s FA Score shows that 0 FA rating(s) are green whileKTTA’s FA Score has 1 green FA rating(s).

  • ETXPF’s FA Score: 0 green, 5 red.
  • KTTA’s FA Score: 1 green, 4 red.
According to our system of comparison, KTTA is a better buy in the long-term than ETXPF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

KTTA’s TA Score shows that 5 TA indicator(s) are bullish.

  • KTTA’s TA Score: 5 bullish, 4 bearish.

Price Growth

ETXPF (@Biotechnology) experienced а 0.00% price change this week, while KTTA (@Biotechnology) price change was -8.68% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +9.04%. For the same industry, the average monthly price growth was +14.90%, and the average quarterly price growth was +1.90%.

Reported Earning Dates

KTTA is expected to report earnings on Mar 24, 2025.

Industries' Descriptions

@Biotechnology (+9.04% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ETXPF($76M) has a higher market cap than KTTA($6.59M). ETXPF YTD gains are higher at: 0.000 vs. KTTA (-71.879).
ETXPFKTTAETXPF / KTTA
Capitalization76M6.59M1,153%
EBITDAN/A-15.49M-
Gain YTD0.000-71.879-
P/E RatioN/AN/A-
RevenueN/A0-
Total CashN/A9.36M-
Total DebtN/A0-
TECHNICAL ANALYSIS
Technical Analysis
KTTA
RSI
ODDS (%)
Bullish Trend 1 day ago
85%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
83%
Momentum
ODDS (%)
Bearish Trend 1 day ago
90%
MACD
ODDS (%)
Bullish Trend 1 day ago
79%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
90%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
90%
Advances
ODDS (%)
Bullish Trend 9 days ago
72%
Declines
ODDS (%)
Bearish Trend 3 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
88%
Aroon
ODDS (%)
N/A
View a ticker or compare two or three
Interact to see
Advertisement
KTTA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BLNK0.870.08
+10.68%
Blink Charging Co
NCMI5.190.15
+2.98%
National CineMedia
FHN20.390.43
+2.15%
First Horizon Corp
HRMY35.600.57
+1.63%
Harmony Biosciences Holdings
AGNCN25.56-0.02
-0.08%
AGNC Investment Corp

ETXPF and

Correlation & Price change

A.I.dvisor indicates that over the last year, ETXPF has been loosely correlated with HOFBF. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if ETXPF jumps, then HOFBF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ETXPF
1D Price
Change %
ETXPF100%
N/A
HOFBF - ETXPF
38%
Loosely correlated
N/A
BOLD - ETXPF
32%
Poorly correlated
+0.85%
KOD - ETXPF
23%
Poorly correlated
+7.65%
KTTA - ETXPF
6%
Poorly correlated
+0.66%
RANI - ETXPF
3%
Poorly correlated
+5.88%
More

KTTA and

Correlation & Price change

A.I.dvisor tells us that KTTA and FATE have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that KTTA and FATE's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KTTA
1D Price
Change %
KTTA100%
+0.66%
FATE - KTTA
32%
Poorly correlated
+19.40%
ACET - KTTA
25%
Poorly correlated
+1.04%
TRAW - KTTA
24%
Poorly correlated
+11.49%
ARVN - KTTA
24%
Poorly correlated
+8.82%
MCRB - KTTA
23%
Poorly correlated
+13.36%
More